Publications by the researcher in collaboration with Patricia Muñoz (20)

2023

  1. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms

    Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922

2020

  1. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella

    Medical Mycology, Vol. 58, Núm. 1, pp. 83-92

  2. Corrigendum to ‘Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect’ [Clinical Microbiology and Infection, Volume 24, (Issue 12) (December 2018) Pages 1343.e1-1343.e4](S1198743X18305214)(10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  3. Corrigendum to “Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect” [Clin Microbiol Infect 24 (12) (December 2018) 1343.e1-1343.e4](10.1016/j.cmi.2018.07.006)

    Clinical Microbiology and Infection

  4. Erratum: Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect (Clinical Microbiology and Infection (2018) 24(12) (1343.e1–1343.e4), (S1198743X18305214), (10.1016/j.cmi.2018.07.006))

    Clinical Microbiology and Infection

2019

  1. Does the composition of polystyrene trays affect candida spp. biofilm formation?

    Medical Mycology, Vol. 57, Núm. 4, pp. 504-509

  2. Persistent Candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 607-614

2018

  1. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

  2. Is biofilm production a prognostic marker in adults with candidaemia?

    Clinical Microbiology and Infection, Vol. 24, Núm. 9, pp. 1010-1015

  3. Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect

    Clinical Microbiology and Infection, Vol. 24, Núm. 12, pp. 1343.e1-1343.e4

  4. Resistance to echinocandins in candida can be detected by performing the etest directly on blood culture samples

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 6

2017

  1. Candida guilliermondii complex is characterized by high antifungal resistance but low mortality in 22 cases of candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 7

2016

  1. Erratum for Marcos-Zambrano et al., Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

    Antimicrobial Agents and Chemotherapy

  2. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels

    Medical Mycology, Vol. 54, Núm. 4, pp. 353-360

2015

  1. Sputum and bronchial secretion samples are equally useful as bronchoalveolar lavage samples for the diagnosis of invasive pulmonary aspergillosis in selected patients

    Medical Mycology, Vol. 53, Núm. 3, pp. 235-240

2014

  1. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 8, pp. 4565-4572

  2. Is Biofilm Production a Predictor of Catheter-Related Candidemia?

    Medical Mycology, Vol. 52, Núm. 4, pp. 407-410

  3. Is catheter-related candidemia a polyclonal infection?

    Medical Mycology

  4. Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 9, pp. 5581-5584

2013

  1. Does identification to species level provide sufficient evidence to confirm catheter-related fungemia caused by Candida albicans?

    Medical Mycology